Get started

BEAT

BEAT Analysis (4H)BEAT has experienced a significant drop, during which it swept a large liquidity pool on the downside. This type of move often indicates a liquidity grab rather than pure bearish continuation. However, the price has not yet shown a strong or convincing recovery, which suggests that the market is still searching for a proper support level. Based on current price action and structure, we expect the price to move further downward toward the marked zone, where a reaction and potential support formation are anticipated. This zone aligns with previous demand and liquidity areas, making it a key level to watch closely. It is important to note that BEAT is a highly volatile and high-risk asset. Due to its volatility and market behavior, it is more suitable for spot trading rather than leveraged positions. Proper risk management is essential when trading this asset. All targets are clearly marked on the chart, and traders are advised to follow the plan accordingly. If you would like us to analyze a coin or altcoin for you, first like this post, then comment the name of your altcoin below. For entry, using a DCA (Dollar-Cost Averaging) strategy within the specified zone is recommended, rather than entering with a single position. This approach helps manage risk and reduce the impact of volatility. If a daily candle closes below the invalidation level, this analysis will be considered invalid, and the scenario should be reassessed. As always, this setup requires patience and confirmation from price action. Manage your risk wisely and trade responsibly.
BINANCE:BEATUSDT.P
by iMoneyTeam
2
Overbought But Still RippingHey guys, BEAT just delivered a monster +47.49% rally in 24 hours and is now trading at $2.68, sitting about 5% below the session high of $2.82. This thing has been absolutely ripping, but now we're at a critical juncture where the technicals are giving us mixed signals and we need to be smart about our next move. Let me break down what's happening and where the opportunities might be. First off, this is a relatively new asset with limited historical data, so we're focusing purely on recent price action and intraday structure. Price is currently in PREMIUM territory according to Smart Money Concepts, trading well above the equilibrium at $1.53 and deep into the sell zone above $1.81. When you're buying premium, you're essentially buying from smart money who accumulated lower, so the risk/reward gets tricky up here. The bullish order block sits at $2.14-$2.03, which was the last major demand zone before this explosive leg up. We've also got an unfilled bullish Fair Value Gap (FVG) between $2.14-$2.20 that could act as a magnet if we see any profit-taking. These imbalances often get filled as price retraces to find more buyers before continuing higher. Now let's talk about the elephant in the room - the overbought conditions. RSI is at 75.4, firmly in overbought territory, and the Money Flow Index (MFI) is even more extreme at 81.1. These readings tell us that buying pressure has been intense, but also that we might be due for a breather. The Stochastic at 78.1 is also elevated, though not quite as extreme. But here's where it gets interesting - the ADX is reading 51.2, which confirms this is a STRONG trend, not just a random spike. ADX above 25 indicates a trending market, and above 50 is considered very strong. This means the momentum behind this move is real and substantial. The MACD is also bullish with the MACD line at 0.2032 above the signal line at 0.1847, showing positive momentum continuation. Moving average alignment is textbook bullish right now. Price is above EMA20 ($2.43), EMA50 ($2.14), and EMA200 ($1.67), which is the classic bull stack you want to see. The Hull Moving Average at $2.60 is providing dynamic support right underneath current price. As long as we hold above these EMAs, the path of least resistance remains upward. Bollinger Bands are showing price above the middle band at $2.40, with the upper band at $2.88 acting as the next resistance ceiling. We're currently in the upper half of the BB range, which typically indicates bullish momentum but also warns of potential mean reversion back toward the middle band. Here's a concern though - volume is below average. Current volume is $12M compared to the average of $15M, and the massive 24h volume of $835M was clearly front-loaded earlier in the session. When price is rising but volume is declining, that's a momentum divergence that often precedes consolidation or pullbacks. We need to see volume pick up again to confirm any breakout above $2.82. The wick analysis is telling us something important too. We've got a 32.1% lower wick showing buyers defended lower levels aggressively, but also a 26.6% upper wick showing sellers pushed back hard at the highs. That upper wick at $2.82 is a rejection signal - there's supply waiting up there. Price structure shows a lower high formation, which is technically bearish, but we've also got a confirmed bullish Break of Structure (BOS) according to Smart Money Concepts. This BOS indicates trend continuation upward is still in play. No Change of Character (CHoCH) has occurred, so the bullish market structure remains intact for now. The key resistance is crystal clear - $2.82 is the 24h high and the level we need to reclaim. Above that, the upper Bollinger Band at $2.88 becomes the next target, and then we're in price discovery mode potentially heading toward $3.00-$3.20. The swing high at $2.50 from earlier has already been taken out, which was a bullish development. On the support side, immediate support is the HMA55 at $2.60, then the EMA20 at $2.43 which coincides with the middle Bollinger Band at $2.40. This $2.40-$2.43 zone would be an ideal pullback entry for anyone who missed the initial move. Stronger support sits at the EMA50 and bullish order block high at $2.14, and then the order block low at $2.03. A 4H close below $2.03 would break the bullish structure and invalidate the continuation thesis. The bearish order block sits at $2.05-$1.87, which is now acting as support after being flipped. This is actually bullish - when you reclaim a supply zone and turn it into demand, that's a sign of strength. The strong low at $1.24 is way down there and would require a major shift in market structure to reach. So what's the trade setup here? If you're not already in, I wouldn't chase at $2.68 in premium territory with overbought indicators. You've got two cleaner plays: wait for a pullback to the $2.40-$2.43 zone (EMA20 + middle BB) where you get better risk/reward, or wait for a confirmed breakout above $2.82 with volume exceeding that 15M average. For a pullback entry around $2.42, you could set stops below the bullish order block at $1.99 (roughly 18% risk) and target $2.82 as TP1 (16% gain), then $3.10 as TP2 (28% gain). That gives you a 1:1 to 1:1.5 risk/reward ratio. For a breakout entry at $2.85, stops could go below $2.60 (9% risk) with targets at $3.20 (12% gain), giving you better than 1:1 R/R. If you're already holding from lower prices, this is a reasonable spot to take some partial profits - maybe 30-40% off the table - and let the rest ride with a trailing stop below $2.43 or $2.14 depending on your risk tolerance. You've already captured a massive move, so locking in some gains while keeping exposure to further upside is the prudent play. The primary scenario I'm watching (55% probability) is a pullback to $2.43 where we consolidate and digest these gains for a bit, then a push back up to challenge $2.82 with proper volume behind it. If we break $2.82 on strong volume, the measured move projects to around $3.10-$3.20. The alternative scenario is an immediate rejection here or at $2.75-$2.82, leading to a sharper correction down to the $2.14 EMA50 and bullish order block for a reaccumulation phase. Invalidation is clear - a 4H close below $2.03 breaks the bullish order block and demand structure, which would signal the trend is losing steam and a deeper correction toward $1.81 or even $1.53 equilibrium is likely. Bottom line: this is a powerful trend with strong momentum, but it's overextended in the short term. The structure is still bullish with BOS confirmed and price above all major EMAs, but overbought indicators and declining volume are flashing caution signs. Don't FOMO into premium zones on a parabolic move. Wait for your pitch - either the dip to support or the confirmed breakout with volume. Patience here will likely reward you with a much better risk/reward entry. What's your take on this setup - are you waiting for the pullback or looking to catch the breakout?
BINANCE:BEATUSDT.PLong
by MonoCoinSignal
Bearish Market Structure Forming - Anticipating a Decline TowardThe price has developed a clear bearish market structure within an ascending channel. After completing what appears to be an A–B–C corrective move , the market has reached point C, where upward momentum has begun to weaken. The reaction from the upper boundary of the channel suggests that buyers are losing strength and a reversal is likely forming. Price also failed to maintain momentum above the mid-channel area, indicating a potential shift from accumulation to distribution. Given the structure and the breakdown signs, my expectation is a downward move toward the lower support zone, projected in the $0.45–$0.35range. This area aligns with previous liquidity levels and the lower boundary of the broader corrective structure, making it a logical target for a deeper retracement if bearish pressure continues.
MEXC:BEATUSDTShort
by ODYSSEY21
BEAT Analysis (1H)The reason for the recent pump in BEAT is the collection of a liquidity pool beneath the chart. Given the series of lower highs and lower lows, a resistance zone has formed on the chart. In this zone, we are looking for sell/short positions. The targets are marked on the chart. A 4-hour candle closing above the invalidation level will invalidate this analysis. Do not enter the position without capital management and stop setting Comment if you have any questions thank you
BINANCE:BEATUSDT.P
by iMoneyTeam
Breaking: QUALCOMM ($QCOM) Shares Dip 5% In Premarket tradingShares in Qualcomm fell more than 5% in Thursdays premarket trading as a disappointing forecast for no growth in its patent licensing business overshadowed a higher-than-expected outlook for sales and profits. The shares fell 4.2% in extended trading on Wednesday, having closed up 1.6% on the day in regular hours. Qualcomm stock is up 14.5% this year. Despite the poor results It is pertinent to note that In 2024, QUALCOMM's revenue was $38.96 billion, an increase of 8.77% compared to the previous year's $35.82 billion. Earnings were $10.14 billion, an increase of 40.24%. Analyst Forecast According to 27 analysts, the average rating for QCOM stock is "Buy." The 12-month stock price forecast is $207.25, which is an increase of 17.85% from the latest price. Technical Outlook As of the time of writing, (NASDAQ: NASDAQ:QCOM ) stock is down 5.11% in Thursday's premarket trading with recent trading session closing with a moderate RSI of 66 however there will be an impediment today on the growth of NASDAQ:QCOM as a gap down is inevitable which is a bearish pattern that leads to further dip. In the case of extreme selling pressure, immediate support lies in the 61.8% fib retracement level. A dip to this could set NASDAQ:QCOM on a bullish course as liquidity has being swept on recent dip.
NASDAQ:QCOMLong
by DEXWireNews
SPLK has been beat down and run down SPLK as you can see has been on this downward trend over the past year essentially however this play had great earnings first and foremost, is in the middle of a conversion going from a software company to a SAAS business model and to align their goals made a big change in leadership asking the CEO to step down and remain as an advisor ( meaning he is leaving on great terms ) to remain with the company says a lot and have asked an executive board member to step up and take on the CEO role moving forward to guide the company through this change being that he comes from a company rich in SAAS ( salesforce ) i feel this transition was not only needed but well deserved. However as we see from the price action the price action still is being run down. However lets take a look at earnings you see positive returns and positive returns per share. Aside from that Cathie Wood also reestablished a new position in SPLK which again are all bullish signs. I am bullish on SPLK and think this too will be a great opportunity when it starts to get some love and attention being that the price is way down from ATH's
SLong
by Stock_Hustle21
BEAT- BEAST is about to be unleashed...Positional/swing tradeBEAT is your prototypical aggressive growth stock- Strong future growth potential with good earning and revenue track record ... If you can overlook its debt level. This beast was tamed for a while after its share price skyrocketed from $25 to almost $80 , but it is ready to unleash its fury again. But first, I think the pullback is in the store facing key resistance lvl in confluence with ichi and BB on the weekly timeframe. In addition, short % of float is around 10%. However, it is a bullish sign when price hovers below the key resistance lvl rather than experiencing outright price rejection. My buy zone is between $45 to $55 for the positional trade. The long term trendline and S/R flip below this price range will act as a strong support. Click the like button and follow me if you like my analysis :D
NASDAQ:BEAT
by Libratus
Planning a trade wayyy before it happens.... HERE'S HOWI'm expecting price to return to the long term descending channel as there is a lot of liquidity there for the taking. I expect this to happen via the channel breaking (wiping out stop losses) then price to continue downward. I have a trade idea already generated before price even reaches that destination, so when it does I am fully prepared for any scenario. If you can try and look to the future then you will get a better feel for the markets. I struggled to explain this one, sorry. Happy trading!
Short
by joebrownFX
6
LET THE MARKET SHOW YOU WHERE TO GONotice the 5 touches of previous resistance marked by the blue arrows. This "strong level" entices people to sell and place their stops just above the level. See how price begins to fall from this level marked at the red arrow? This also draws more sellers into the market; people don't want to miss out; then BOOM! Price breaks the level and wipes out everyone who shorted earlier. The banks know people place stops here. It is great liquidity for them to take then drive price further down. Think of it like this, if you could enter above the level with a sell order you are already getting a better entry price. Currently CHF and JPY are strong as they are safe haven currencies, so it is a good time to short commodity currencies against them. I'm in this trade. Results to follow.
by joebrownFX
let's BEAT it..It might be of some concern to shareholders to see the BioTelemetry, Inc. (NASDAQ:BEAT) share price down 15% in the last month. But that doesn't undermine the fantastic longer term performance (measured over five years). Indeed, the share price is up a whopping 538% in that time. So it might be that some shareholders are taking profits after good performance. But the real question is whether the business fundamentals can improve over the long term. Anyone who held for that rewarding ride would probably be keen to talk about it. See our latest analysis for BioTelemetry To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price. During the last half decade, BioTelemetry became profitable. Sometimes, the start of profitability is a major inflection point that can signal fast earnings growth to come, which in turn justifies very strong share price gains. Since the company was unprofitable five years ago, but not three years ago, it's worth taking a look at the returns in the last three years, too. We can see that the BioTelemetry share price is up 446% in the last three years. During the same period, EPS grew by 68% each year. That makes the EPS growth rather close to the annualized share price gain of 76% over the same period. So you could reasonably conclude that investor sentiment towards the stock has remained pretty steady, over time. Rather, the share price has approximately tracked EPS growth. get free idea bit.ly
NASDAQ:BEATLong
by ShukriMahadi
BEAT will benefit? Encouraging Near-Term Outlook for Medical SecThe Zacks Medical Services industry comprises third-party service providers and caregivers appointed by core healthcare companies for economies of scale. The industry includes pharmacy benefit managers, contract research organizations (CRO), mobile and wireless medical technology companies, third-party testing labs, surgical facility providers and healthcare workforce solutions providers among others. Over the past few years, the healthcare industry has strategically moved from volume to value-based care. This changing pattern of care calls for efficient and better-quality facilities, thus gradually increasing the need to appoint specialized external service providers. In recent times, biotechnology and pharmaceutical companies have often been seen outsourcing clinical development and data solution services to improve quality of medical care at competitive costs. With growing importance of effective healthcare management, the medical service industry has become an integral part of the modern healthcare mechanism. Here are the industry’s three major themes: With a significant reduction in regulatory and tax burden on U.S. healthcare companies, the space is finally making progress in terms of technology adoption. This is creating opportunities for mobile and wireless medical technology companies. This apart, thanks to the specialized skills and advanced techniques of surgical facility providers, treatments are becoming less invasive with shorter recovery times. In the future, concepts like ‘bed less hospitals’ are expected to become popular. Currently, third-party laboratory testing providers and contract research organizations are also experiencing increasing demand, thanks to the growing need for complex tests, services and clinical research. For the conventional biotechnology and pharmaceutical firms, clinical trials account for the majority of their drug development costs. These firms are right now looking to outsource clinical trials to control escalating costs related to therapeutic complexities, regulatory demands, and timelines. Going by a report published in Contract Pharma, outsourcing to CROs is anticipated to witness 7.4% CAGR through 2019, with a market penetration rate of 72% by 2020. Overall, the global market for clinical trial services is forecast to grow 12% year on year to 2021 (The Business Research Company). With rising cognizance about the benefits of specialized medical caregiving, the need for healthcare workforce/staffing service providers has increased significantly. For example, the demand for nurses has increased manifold and is expected to remain high. Going by a study published by Georgetown University, the economy will create 1.6 million job openings for nurses through 2020.
NASDAQ:BEATLong
by ShukriMahadi